Frost & Sullivan: Clinical Diagnostics & Research Tools
Next Generation Diagnostics program provides a truly end-to-end perspective analysis of ‘white space’ opportunities across IVD and Genomics markets. It enables companies to stay ahead of the shift to Direct to Consumer testing, track investments in Biomarkers (companion diagnostics) and adapt new business models in Clinical Laboratory services and Lab Automation markets.
Know anyone building innovative solutions that belong in this 'Clinical Diagnostics & Research Tools'?
In vitro diagnostics (IVDs) play a key role in today’s healthcare system. Their importance has been strongly highlighted in the global effort to combat and control the spread of SARS-CoV-2, the virus …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our